Raymond James Financial’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.36M Sell
151,555
-49,469
-25% -$454K ﹤0.01% 3767
2026
Q1
$1.87M Sell
201,024
-130,273
-39% -$1.28M ﹤0.01% 3413
2025
Q4
$2.32M Sell
331,297
-78,925
-19% -$496K ﹤0.01% 3152
2025
Q3
$2.34M Sell
410,222
-37,121
-8% -$198K ﹤0.01% 3058
2025
Q2
$2.14M Sell
447,343
-27,341
-6% -$157K ﹤0.01% 3033
2025
Q1
$4.12M Buy
474,684
+248,654
+110% +$2.61M ﹤0.01% 2462
2024
Q4
$2.74M Buy
+226,030
New +$3.16M ﹤0.01% 2732

Other funds holding NEOG

Raymond James Financial's NEOG Position: Q2 2026 in Review

Raymond James Financial reduced its Neogen (NEOG) stake by 25% in Q2 2026, selling an estimated $454K and leaving 151,555 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #3767.

Raymond James Financial first reported a position in NEOG in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.12M in Q1 2025. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Raymond James Financial held 151,555 shares of Neogen worth $1.36M as of Q2 2026.
  • Raymond James Financial sold 49,469 Neogen shares in Q2 2026, an estimated $454K.
  • Neogen made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3767 holding.
  • Raymond James Financial first reported a position in Neogen in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Neogen position peaked at $4.12M in Q1 2025.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.